We are live on ! Find out more
ONC

BeOne Medicines Ltd
ONC

204 hedge funds and large institutions have $7.27B invested in BeOne Medicines Ltd in 2024 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 90 increasing their positions, 45 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 45

43% more funds holding in top 10

Funds holding in top 10: 7 → 10 (+3)

9% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 35

8% more call options, than puts

Call options by funds: $14.2M | Put options by funds: $13.2M

0% more funds holding

Funds holding: 203 → 204 (+1)

0.11% more ownership

Funds ownership: 3.61% → 3.72% (+0.11%)

11% less capital invested

Capital invested by funds: $8.14B → $7.27B (-$872M)

Holders
204
Holders Change
+1
Holders Change %
+0.49%
% of All Funds
2.94%
Holding in Top 10
10
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+42.86%
% of All Funds
0.14%
New
38
Increased
90
Reduced
45
Closed
35
Calls
$14.2M
Puts
$13.2M
Net Calls
+$1.03M
Net Calls Change
+$365K

Top Buyers

1
Capital International Investors
Capital International Investors
California
+$117M
2
VPC
Vestal Point Capital
New York
+$52.3M
3
Bank of America
Bank of America
North Carolina
+$28.5M
4
SCM
Soleus Capital Management
Connecticut
+$23.8M
5
Artisan Partners
Artisan Partners
Wisconsin
+$23.3M

Top Sellers

1
Invesco
Invesco
Georgia
-$43.4M
2
Morgan Stanley
Morgan Stanley
New York
-$32.1M
3
Goldman Sachs
Goldman Sachs
New York
-$25.1M
4
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$22.2M
5
AI
Axiom Investors
Connecticut
-$15.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
AF
201
Advisornet Financial
Minnesota
$313 +$322 +2 New
SL
202
Salomon & Ludwin
Virginia
$313 +$322 +2 New
AWM
203
Abound Wealth Management
Tennessee
$157 – – –
HNB
204
Huntington National Bank
Ohio
$156 -$483 -3 -75%
AI
205
Axiom Investors
Connecticut
– -$15.1M -83,985 Closed
N
206
Nuveen
North Carolina
– -$11.4M -63,200 Closed
CSS
207
Cubist Systematic Strategies
Connecticut
– -$5.43M -30,096 Closed
Norges Bank
208
Norges Bank
Norway
– -$4.96M -27,477 Closed
MICM
209
Matthews International Capital Management
California
– -$3.77M -20,902 Closed
PCIG
210
Partners Capital Investment Group
Massachusetts
– -$2.76M -15,316 Closed
Jane Street
211
Jane Street
New York
– -$2.19M -13,580 Closed
CCIA
212
Campbell & Co Investment Adviser
Maryland
– -$1.32M -7,313 Closed
Russell Investments Group
213
Russell Investments Group
United Kingdom
– -$1.2M -6,650 Closed
TI
214
Trexquant Investment
Connecticut
– -$1.1M -6,090 Closed
VF
215
Virtu Financial
New York
– -$959K -5,319 Closed
FTDI
216
First Trust Direct Indexing
Massachusetts
– -$506K -2,808 Closed
D.E. Shaw & Co
217
D.E. Shaw & Co
New York
– -$492K -2,727 Closed
HCA
218
Harbour Capital Advisors
Virginia
– -$462K -2,545 Closed
FRM
219
Fox Run Management
Connecticut
– -$406K -2,253 Closed
Cerity Partners
220
Cerity Partners
New York
– -$392K -2,174 Closed
JF
221
Jump Financial
Illinois
– -$354K -1,961 Closed
AIM
222
Aigen Investment Management
New York
– -$295K -1,635 Closed
VA
223
Vident Advisory
Georgia
– -$254K -1,409 Closed
AG
224
Algert Global
California
– -$250K -1,386 Closed
XT
225
XTX Topco
Cayman Islands
– -$246K -1,366 Closed
6 7 8
9
10

ONC Hedge Fund Activity: Q1 2024 in Review

204 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q1 2024, worth a combined $7.27B — down 11% from $8.14B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new ONC positions and 35 closed out — a net gain of 3 holders — while 90 added to existing stakes and 45 trimmed.

The largest buyer was Capital International Investors, adding an estimated $117M. The largest seller was Invesco, cutting an estimated $43.4M.

  • 204 institutional investors held BeOne Medicines Ltd (ONC) as of Q1 2024, up from 203 in Q4 2023.
  • Funds reported $7.27B of BeOne Medicines Ltd stock for Q1 2024, down 11% quarter-over-quarter.
  • 38 funds opened new BeOne Medicines Ltd positions in Q1 2024 and 35 closed out, a net change of +3 holders.
  • The largest BeOne Medicines Ltd buyer in Q1 2024 was Capital International Investors, an estimated $117M added.
  • The largest BeOne Medicines Ltd seller in Q1 2024 was Invesco, an estimated $43.4M sold.

Based on aggregated 13F filings for Q1 2024.